SYSTEM-WIDE MAPPING OF ACTIVATED CIRCUITRY IN EXPERIMENTAL SYSTEMIC INFLAMMATORY RESPONSE SYNDROME

Sina A Gharib1, Daniel Mar, Karol Bomsztyk

  • 1*Computational Medicine Core †Center for Lung Biology ‡Division of Pulmonary and Critical Care Medicine §Department of Medicine, University of Washington, Seattle, Washington.

Shock (Augusta, Ga.)
|November 5, 2015
PubMed

Insights

Sepsis-induced multiple organ dysfunction syndrome (MODS) involves complex pathway dysregulation. This study identified key gene drivers regulated by epidermal growth factor receptor, offering potential therapeutic targets for critical illness.

Area of Science:

  • Critical care medicine
  • Molecular biology
  • Systems biology

Background:

  • Sepsis-induced multiple organ dysfunction syndrome (MODS) is a leading cause of death in critically ill patients.
  • Effective therapeutic interventions for MODS remain limited.
  • Ventilator-associated pneumonia is a common trigger for early MODS.

Purpose of the Study:

  • To systematically identify dysregulated molecular pathways in lung, liver, and kidney during early MODS.
  • To construct a network of Systemic Inflammatory Response Syndrome (SIRS)-associated genes.
  • To identify potential therapeutic targets for sepsis-induced MODS.

Main Methods:

  • Utilized a clinically relevant murine model of SIRS and early MODS induced by ventilator-associated pneumonia.
  • Focused on commonly activated processes across multiple organs (lung, liver, kidney).
  • Constructed an SIRS-associated gene network based on pathway connectivity.

Main Results:

  • Identified several key molecular drivers of early MODS.
  • Discovered that epidermal growth factor receptor regulates the expression of these identified drivers.
  • Revealed common dysregulated pathways across affected organs.

Conclusions:

  • An integrative, unbiased network-based approach can unravel mechanisms in system-wide disorders like MODS.
  • Epidermal growth factor receptor signaling is implicated in early MODS pathogenesis.
  • The identified gene drivers represent potential therapeutic targets for sepsis-induced MODS.